4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001140361-18-003889
Options or other derivatives
- Chief Medical Officer acquired 45,443 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Benaim Ely · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-01-26 | Grant or award : show line 1 in the form Stock Option (right to buy) | +45,443 | $2.29 | 2028-01-26 | 45,443 | 45,443 | D |
Loading xslF345X03/form4.xml…